Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by wildbird1on May 01, 2023 9:04am
221 Views
Post# 35422473

RE:RE:RE:RE:RE:RE:72% CR at any point in time.

RE:RE:RE:RE:RE:RE:72% CR at any point in time.NotinKansas, thank's for responding to my post. I like it when peoples take the the time to respond.
I read your last 5 posts.

Let's see....
1) You pretend that the "non-responding patients collect at the bottom"(your exact word) of the Swimmer Plot.
2) In the Nov,2022 Swimmer Plot there was 10 NR(red dot) patients at the bottom of the Swimmer Plot.
3) In the April,2023 Swimmer Plot there is 9 NR(red dot) patients at the bottom of the Swimmer Plot.
4) In the April,2023 Swimmer Plot, 9 new patients have completed their 90 days assesment.
5) Out of these 9 new patients, we can easily assume that at the least 2-3 patients would end up NR(red dot) at 90 days, let's make it 3NR for now(I like 3).

Now let's do the math....
In the Nov,2022 Swimmer Plot there was 10 NR(red dot) patients at the bottom of the Swimmer Plot + 3 NR(red dot) /9 new patients for a total of 13 NR(red dot) patients.

In short ...The number of NR(red dot) patients at the bottom of the April,2023 Swimmer Plot should have gone up to 13 NR(red dot) patients.

Houston!!!! We have a big problem!!! Because instead of going up to 13NR, the NR(red dot)number went down to 9 NR(red dot) patients at the bottom of the April,2023 Swimmer Plot.

There is only 2 possible reasons for the above.
- NotinKansas your numbers are misleading.
- Or TLT treatment is so good that out of the 9 new patients treated 10 are CR, that is why the NR (red dot) number went down by 1 in the April,2023 Swimmer Plot.
That is what you call one hell of a good treatment( I didn't know TLT treatment was so good that it could resuscitate patients).

NotinKansas you made a smart move by keeping your TLT shares.

Will be waiting for your answer.






<< Previous
Bullboard Posts
Next >>